Regatta Capital Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$355K Sell
918
-16
-2% -$5.93K 0.05% 161
2026
Q1
$273K Buy
934
+50
+6% +$16.4K 0.04% 178
2025
Q4
$310K Sell
884
-14
-2% -$4.73K 0.05% 163
2025
Q3
$290K Sell
898
-143
-14% -$44.5K 0.05% 175
2025
Q2
$405K Buy
1,041
+30
+3% +$12.1K 0.07% 153
2025
Q1
$440K Buy
1,011
+123
+14% +$49.4K 0.09% 130
2024
Q4
$328K Buy
888
+145
+20% +$60.7K 0.06% 148
2024
Q3
$386K Sell
743
-38
-5% -$20.3K 0.08% 142
2024
Q2
$423K Buy
781
+6
+0.8% +$3.17K 0.09% 130
2024
Q1
$402K Buy
775
+39
+5% +$19.4K 0.09% 133
2023
Q4
$347K Sell
736
-3
-0.4% -$1.39K 0.09% 131
2023
Q3
$322K Buy
739
+249
+51% +$113K 0.1% 130
2023
Q2
$218K Buy
+490
New +$226K 0.07% 158

Other funds holding ELV

Regatta Capital Group's ELV Position: Q2 2026 in Review

Regatta Capital Group reduced its Elevance Health (ELV) stake by 1.7% in Q2 2026, selling an estimated $5.93K and leaving 918 shares worth $355K. The position accounts for 0.05% of the portfolio, ranked #161.

Regatta Capital Group first reported a position in ELV in Q2 2023 and has held it in 13 quarters since. The position peaked at $440K in Q1 2025. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Regatta Capital Group held 918 shares of Elevance Health worth $355K as of Q2 2026.
  • Regatta Capital Group sold 16 Elevance Health shares in Q2 2026, an estimated $5.93K.
  • Elevance Health made up 0.05% of Regatta Capital Group's portfolio in Q2 2026, its #161 holding.
  • Regatta Capital Group first reported a position in Elevance Health in Q2 2023 and has held it in 13 quarters since.
  • Regatta Capital Group's Elevance Health position peaked at $440K in Q1 2025.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Regatta Capital Group's 13F filing for Q2 2026, filed 12 Aug 2026.